NCT00815802

Brief Summary

Direct DNA amplification, viral isolation and specific antibody measurement in saliva

  1. 1.From children in day care centers (samples collection will take place during a single week)
  2. 2.From children coming at the emergency department of our hospital during a three months period.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
655

participants targeted

Target at P75+ for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2007

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

December 29, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 30, 2008

Completed
Last Updated

December 30, 2008

Status Verified

December 1, 2008

First QC Date

December 29, 2008

Last Update Submit

December 29, 2008

Conditions

Cytomegalovirus

Keywords

Children in day care centerscytomegalovirus excretion

Outcome Measures

Primary Outcomes (1)

  • One week trial of saliva sampling for cytomegalovirus detection in day-care centers.

Secondary Outcomes (1)

  • Percentage of chidrens with CMV excretion among those coming at the Emergency department of Limoges teacher Hospital (CHU). Validation of the process from samples collection to interpretation of results

Eligibility Criteria

Age3 Months - 6 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

child aged from 3 month to 6 years in day care centers or in emergency department.

You may qualify if:

  • parents consent
  • child aged from 3months to 6 years
  • child in day care centers or emergency department

You may not qualify if:

  • Refuse of participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bactériologie-Virologie

Limoges, 87, France

Location

Study Officials

  • Sophie ALAIN, MD

    University Hospital, Limoges

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 29, 2008

First Posted

December 30, 2008

Study Start

July 1, 2007

Last Updated

December 30, 2008

Record last verified: 2008-12

Locations

FR(1)